The study aims to determine the immunogenicity of low-dose, short course, intradermal hepatitis B vaccination using the recombinant type.Specifically, it aims to: 1) determine the seroconversion rate after short course, low-dose, intradermal hepatitis B vaccine using recombinant type; 2) determine whether short course, low-dose, intradermal hepatitis B vaccination will produce a rapid and early seroconversion among the vaccines.
Your rating
no rate selected
email is required
email is invalid
affiliation is required